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by carrier-mediated diffusion – i.e. the salvage of the
purine – or more specifically as a ligand for P1 purinergic
receptors, the adenosine receptors. Various combina-
tions of CD73 and one of the four subtypes of these re-
ceptors (A1, A2a, A2b and A3) have been described in
different tissues involving either autocrine or paracrine
stimulation, for example in intestinal epithelia (Strohmeier
et al., 1997), the microvascular endothelial bed (Lennon
et al., 1998), kidney (LeHir and Kaissling, 1993), central
nervous system (Richardson et al., 1987) and the immune
system (Resta et al. 1998). Because of such close coop-
eration one might speculate that expression of CD73 and
the cooperating subtype of the adenosine receptor could
be coordinately regulated, especially in situations where
both are expressed on the surface of the same cell.
Regulation of CD73 expression – presumably always
on the transcriptional level – was suggested by earlier re-
ports on rat mesangial cells (IL-1ß/TNFα; Savic et al.,
1990), chicken myoblasts (signaling via extracellular
laminin; Méhul et al., 1993) and HL60 cells (phorbol-
myristate-acetate mediated induction of differentiation;
Spychala et al., 1997) and could be studied in more detail
after sequencing and characterization of the promoter re-
gion of the human CD73 gene (Hansen et al., 1995; Spy-
chala et al., 1999). A cross-regulation of CD73 expression
mediated by adenosine and adenosine receptor signal-
ing (Stefanovic et al., 1993; Narravula et al., 2000) seems
to be particularly interesting.
Expression of CD73 has been studied extensively in the
human lymphoid system (for a review see Resta et al.,
1998). Expression in B cells is regulated at several stages of
differentiation. Maturation from the stage of cord blood or
fetal spleen is followed by an increase in CD73 expression
during the first six months of life until B cells achieve the ca-
pacity for IgG antibody responses. Seventy-five percent of
adult peripheral blood, spleen and lymph node B cells ex-
press CD73. Usually B cells in primary follicles and resting
memory B cells are CD73+ while germinal center B cells are
CD73–. Among B cell lines, lymphoblastoid lines (LCLs) are
characterized by varying degrees of CD73 expression,
whereas the typical Burkitt lymphoma line is usually devoid
of CD73 activity (Gutensohn and Jahn, 1988).
Regulation of the expression of the A2a adenosine re-
ceptor had not yet been studied in conjunction with ecto-
nucleotidases. A2a receptor expression in the pheochro-
mocytoma cell line PC12 is stimulated either by hypoxia
(Kobayashi and Millhorn, 1999) or via nerve growth factor
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In the human B cell line P493-6 two mitogenic signals,
the Epstein-Barr virus nuclear antigen 2 (EBNA2) and
myc, can be independently regulated by means of an
estrogen receptor fusion construct or an inducible ex-
pression vector, respectively. Shut off of EBNA2, ei-
ther in the presence or absence of myc, leads to a sig-
nificant increase in enzymatic activity and surface
expression of ecto-5´-nucleotidase (CD73) as well as
an increased adenosine receptor response in cyclic
AMP formation. Shut off of myc expression has a
small additional positive effect on CD73 activity.
Among the four different subtypes of adenosine re-
ceptors, the A2a receptor exclusively is subject to
regulation in this system, which is substantiated by
pharmacologic data (specific agonists and inhibitors),
as well as on the mRNA level. With up-regulated CD73
and A2a, cells also respond to 5´-AMP with increased
cyclic AMP formation. Turn on of EBNA2 has the re-
verse effect of repression of CD73 and A2a expres-
sion. The time course of both induction and repres-
sion of CD73 and A2a is rather slow.
Key words: A2a mRNA/5´-AMP/c-myc /Cyclic AMP/
EBNA2.
Excretion of ATP into the extracellular space under phys-
iological conditions and its subsequent breakdown by a
cascade of ecto-nucleotidases has been well established
in various tissues and cell types. The enzymes involved,
among others an ecto-apyrase (CD39) and the ecto-5´-
nucleotidase CD73, have been studied on molecular,
structural and functional levels (Zimmermann, 1992;
Wang and Guidotti, 1996; Resta et al., 1998; Knöfel and
Sträter, 1999; Mulero et al., 1999). The end product of this
breakdown, adenosine, may serve either the re-uptake
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signaling (Malek et al., 1999). Transcription of the A2a re-
ceptor gene in a neuroblastoma cell line (SH-SK5Y) is in-
creased by phorbol ester via protein kinase C (Peterfre-
und et al., 1997).
Here we present evidence for coordinated regulation
of the expression of CD73 and the A2a adenosine recep-
tor in a B cell line. In this line (P493-6) two mitogenic sig-
nals, the Epstein-Barr virus nuclear antigen 2 (EBNA2)
and myc, can be independently regulated via an estrogen
receptor fusion construct (EBNA2) and via expression
from a stably-transfected vector with the Tet off system
(myc), respectively (Pajic et al., 2000, 2001). Depending
on which of the two mitogenic signals is turned on or off,
the P493-6 cells show different phenotypes as given in
Table 1. Cells change from a more lymphoblastoid-like
(with both mitogens or with EBNA2 alone active) to a
Burkitt lymphoma-like phenotype (with only myc active)
and finally stop dividing (when both mitogens are shut
off). For convenience the four different states will be num-
bered in the following according to this scheme.
When the 4 different states of P493-6 cells are com-
pared in their enzymatic (CD73) activity (tested on intact
cells) and in their response to stimulation with the A2
adenosine receptor-specific agonist N-ethyl-carboxami-
do-adenosine (NECA), the results given in Figure 1 are
obtained. Whereas we see a more steady increase in the
enzymatic activity going from state 1 to 4, the most pro-
nounced effect on the adenosine receptor response, as
measured by cyclicAMP formation, is caused by the shut
off of EBNA2 (going from state 2 to 3). Statistically signif-
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Table 1 Phenotypes of P493-6 Cells.
State EBNA 2 c-myc Phenotype
1 + + Lymphoblastoid cell line (LCL)
2 + – Lymphoblastoid cell line (LCL)
3 – + Burkitt lymphoma group I
4 – – ‘Resting’
P493-6 cells were grown as previously described (Pajic et al.,
2000, 2001) in RPMI 1640 medium supplemented with 10% fetal
calf serum, 2 mM glutamine, 100 U/ml penicillin, and 100 µg/ml
streptomycin, in an atmosphere containing 5% CO2. Occasionally,
cultures were subjected to selection by hygromycin B (150 µg/ml
final concentration) for the maintenance of the episomal myc ex-
pression vector. To activate the estrogen receptor-EBNA2 fusion
protein, the medium was supplemented with 1 µM ß-estradiol. For
the suppression of myc expression 1 µg/ml tetracycline was
added. For the removal of estradiol and/or tetracycline, cells were
washed 3 times in RPMI 1640 and re-suspended in complete
medium without hormone and/or tetracycline. Viability of the cells
as checked by the trypan blue exclusion test varied between differ-
ent cultures (65 – 90%) but was independent of the state.
Fig. 1 Enzymatic Activity of CD73 and Adenosine Receptor Response of P493-6 Cells with Different Phenotypes.
CD73 activity (5´N, white bars) and cyclicAMP (cAMP) production in response to 5 µM NECA (gray bars). 1: EBNA2+/myc+; 2:
EBNA2+/myc-; 3: EBNA2-/myc+; 4: EBNA2-/myc-. The number of independent experiments using different cultures is given. Statisti-
cally significant differences (** = 1% level, * = 5% level) with respect to state 1 are indicated (Mann-Whitney U-test). CD73 activity was
measured on intact cells under isotonic conditions at 37°C using [8-14C]5´-AMP as a substrate. After stopping the reaction with
trichloroacetic acid the substrate and the products (adenosine and inosine, derived from adenosine in a second reaction catalyzed by
adenosine deaminase) were separated by thin layer chromatography on PEI cellulose and quantified by scintillation counting. The part
of total 5´-nucleotidase activity (between 65 – 90%) that is inhibitable by 200 µM α,ß-methylene-adenosinediphosphate (AOPCP) is de-
fined as CD73. As shown previously, detergent extraction does not liberate additional CD73 activity (Gutensohn et al., 1980). On the oth-
er hand, viability has no influence on the activity of this membrane enzyme. Values given are the average of duplicate determinations
performed, each in the presence and absence of AOPCP. For the adenosine receptor response 5.4×106 cells in a total volume of 300 µl
RPMI 1640 were incubated in the presence of the phosphodiesterase inhibitor Ro 20 – 1724 (final concentration 175 µg/ml) and the in-
dicated concentrations of ligand [N-ethyl-carboxamido-adenosine (NECA), CGS 21680, or 5´-AMP] for 10 min at 37°C. After a short
centrifugation (5000 g) the supernatant was removed and the cell sediment resuspended in 110 µl 0.1 M HCl. After a further short cen-
trifugation (10000 g) 100 µl of the supernatant were taken and its cyclicAMP (cAMP) content determined using the ‘correlate-EIA direct
cyclic AMP enzyme immunoassay kit’ (AssayDesigns Inc., Frankfurt, Germany). Values were calculated by comparison with a standard
curve established in each individual experiment. cAMP production, corrected for background in the absence of ligand, was related to
the number of viable cells in the sample. Values given are the average of duplicate determinations.
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icant differences with respect to state 1 are indicated in
Figure 1, in addition CD73 activity in state 4 is different
from that in state 3 on the 5% level. Such a difference be-
tween states 3 and 4, however, is not seen in the adeno-
sine receptor response. In a preliminary experiment, sur-
face expression of the CD73 molecule was monitored by
impulse cytofluorimetry using two different monoclonal
antibodies, CD73.5-IFH-5N2 and CD73.6-IFH-5N4 (CD
workshop; Thompson et al., 1995), and corresponds to
the enzymatic activity. Within the same experiment – as a
control for the phenotype of the cells in the four different
states – down-regulation of CD21 and up-regulation of
CD38 (data not shown) were seen as previously de-
scribed (Pajic et al., 2001). The increases in either CD73
activity or adenosine receptor response vary consider-
ably between experiments (which is evident by the rather
wide error margins in Figure 1); however, when compared
with each other within the same experiments they are
correlated with r=0.78.
The increases in CD73 enzymatic activity and the
adenosine receptor response as seen in states 3 and 4
also render the cells more susceptible to stimulation with
5´-AMP. In several experiments the cAMP response to
5 µM 5´-AMP increased up to 10-fold from state 1 to
states 3 or 4, respectively, of the cells, whereas the back-
ground cAMP production in the absence of 5´-AMP re-
mained at a low level (100 – 200 pmol/107 cells). In this sit-
uation the nucleotide serves as a precursor of the ligand
adenosine. Given the Km value of CD73, the activity of
5.4×106 cells in state 3 should be sufficient to convert 5´-
AMP (5 µM) almost quantitatively to adenosine within the
10 min incubation period. This shows that the two com-
ponents, enzyme and receptor, when more highly ex-
pressed on the surface of the same cell do in fact coop-
erate in signaling starting from extracellular nucleotides.
The increase in the adenosine receptor response seen
in states 3 and 4 is due to the activity of the A2a subtype as
shown by two sets of data: (i) the same responses as
shown in Figure 1 for the general agonist NECA can be
achieved with the A2a-specific agonist CGS 21680 (5 µM).
The response to NECA in states 3 and 4 is inhibited by
75% with the A2a-specific inhibitor chlorostyrylcaffeine
(5 µM) and is not influenced by the A2b-specific inhibitor al-
loxazine (5 µM). (ii) When tested by semi-quantitative RT-
PCR, out of the four different adenosine receptor subtypes
only the mRNA level of the A2a subtype shows a steady
and consistent, albeit slow, increase within 24 h after shut
down of EBNA2 (in the absence of myc; going from state 2
to 4). A representative experiment is shown in Figure 2.
This suggests that the up-regulation of the A2a receptor
expression takes place on the transcriptional level.
A reverse effect, i.e. down-regulation of CD73 expres-
sion and activity as well as of the adenosine receptor re-
sponse to NECA after turn on of EBNA2 in the presence
of myc (going from state 3 to 1), could also be observed
in several experiments and this too is a rather slow
process as shown by representative examples in Fig-
ure 3A and 3B. Figure 3B, in addition, demonstrates the
effect on the adenosine receptor response of a change in
both directions (state 3 to 1 and 1 to 3, respectively).
Thus, in this cell line A2a receptor expression also corre-
sponds to the state of the mitogenic stimuli.
A cooperation of CD73 and one of the adenosine re-
ceptors and therefore a coordinate regulation of the func-
tional expression of these components – as outlined
above– would make sense in the context of a signaling
system. However, experimental evidence for such a co-
ordinate regulation, as presented here for the B cell line
P493-6, will not necessarily reveal the underlying mecha-
nism nor will it tell us anything about the benefits of the
signaling for the cell in this particular situation.
In the P493-6 system, in order to keep the estrogen re-
ceptor-EBNA2 fusion protein in an active state, the medi-
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Fig. 2 Time Course of mRNA Expression in P493-6 Cells after
a Change in Phenotype.
Semi-quantitative RT-PCR. mRNA levels of the 4 different sub-
types of adenosine receptors after a switch from state 2 to state
4 (shut off of EBNA2 in the absence of myc).
A cDNA pool was synthesized by reverse transcription of total
RNA with AMV reverse transcriptase (Promega) using a poly-
(dT)18-primer. The semi-quantitative RT-PCR is based on a prin-
ciple first published by Gilliland et al. (1990). In short, the target
cDNA and a known amount of a heterologous competitor DNA
are allowed to compete for an identical pair of primers within the
same reaction. The competitor is constructed in order to yield an
amplification product differing slightly in length from the target
product. The products are separated, signals registered digitally
using the NIH Image 1.61 or the Scion Image 4.0.2 program and
quantified densitometrically. After correction for background the
ratio of target and competitor products was calculated in relative
units. These were standardized in relation to values for the
housekeeping gene pgk1 obtained from the same cDNA pool by
the same procedure. The primers used in the RT-PCR were cho-
sen in order to allow a clear distinction between the 4 different
subtypes of adenosine receptors:
A1: Forward 5´ TTCTGCTTCATCGTGTCGC 3´ (133)
Reverse 5´ CTTCTTGTTGAGCTGCTTGC 3´ (641)
A2a: Forward 5´ TCCTCGGTGTACATCACG 3´ (16)
Reverse 5´ AAGAGACAGGCCACTTGGC 3´ (502)
A2b: Forward 5´ GACTTCTACGGCTGCCTCTTC 3´ (219)
Reverse 5´ GCAGCTTTCATTCGTGGTTC 3´ (497)
A3: Forward 5´ GGCCAATGTTACCTACATCACC 3´ (28)
Reverse 5´ GATGTCAAGATAGATGGCGC 3´ (599)
pgk1: Forward 5´ ATGATTATTGGTGGAATGGCT 3´
Reverse 5´ TCATCCATGAGAGCTTTGGTTCC 3´
Numbers in parentheses give the 5´ nucleotide positions of the
primers in the open reading frame of the respective cDNA.
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um is supplemented with 1 µM ß-estradiol. This applies to
states 1 and 2. Could CD73 and A2a receptor expression
simply depend on the presence or absence of the hor-
mone with exclusion of EBNA2? In fact, human breast
cancer cell lines expressing high levels of endogenous or
transfected estrogen receptor (ER) show a strong sup-
pression of CD73 when compared with their ER-negative
counterparts (Spychala et al., unpublished). Although this
suppression and activation (in the ER-negative lines) is
also demonstrated on the mRNA and promoter activation
level, these authors interpret this as an indirect estrogen
effect, since the promoter of the human CD73 gene does
not contain an estrogen response element up to 1.9 kb
upstream (Hansen et al., 1995). The situation in B cells is
less clear. A reporter (chloramphenicol acetyl transferase)
containing an estrogen response element in its promoter
transfected into the Burkitt lymphoma line B41 cannot be
stimulated by estrogen unless ER is ectopically ex-
pressed (B. Kempkes, unpublished). Although this exper-
iment has not been performed in the P493-6 cells, it
seems less likely that these B cells express ER at levels
sufficient for a hormone effect. However, even if the re-
pression of CD73 and A2a receptor in states 1 and 2 were
due directly to estradiol, the fact of a coordinate regula-
tion of the two components – although by an unknown
mechanism – would still hold. On the other hand, none of
the factors discussed so far in the literature as participat-
ing in the regulation of either CD73 or A2a receptor
(Hansen et al., 1995; Malek et al., 1999; Spychala et al.,
1999) seem to be components of a signaling pathway
used by the viral factor EBNA2.
Whether, in addition to EBNA2, there is an effect of
myc, or the shut off of myc-expression in P493-6 on the
expression of CD73 and A2a is less clear. A comparison
of states 3 and 4 in Figure 1 suggests that there might be
a slight influence on CD73 but definitely not on the
adenosine receptor response.
The core promoter region of the human CD73 gene
does contain a cAMP response element (CRE site)
(Hansen et al., 1995). The role of this element is discussed
as mediating either suppression or stimulation of promot-
er activity in a tissue-dependent way depending on the
activity of further regulating elements (Spychala et al.,
1999). In other systems, like vascular endothelial cells,
stimulation prevails, in this case mediated by adenosine
and A2b-receptor signaling (Narravula et al., 2000). If this
would hold for the P493-6 cells, up-regulation of CD73
and A2a at the same time would establish an autocatalyt-
ic positive feedback loop for the expression of CD73.
Among the many different surface markers tested by
immunofluorescence in the four different states of P493-
6 cells, CD39 shows a slight decrease in expression
when going from states 1 or 2 to 3 or 4 (Pajic et al., 2001).
However, since this happens on a rather high level,
enough apyrase (CD39) activity should be left to ascer-
tain sufficient breakdown of extracellular ATP by an ecto-
enzyme cascade (CD39 + CD73).
As seen in Figures 2 and 3, the time course of changes in
CD73 and A2a expression after turn on or shut off of EBNA
2 (in the presence or absence of myc, respectively) is rather
slow. Pulse-chase experiments in cultured human chorion-
ic cells highly expressing CD73 showed transit times of
newly synthesized enzyme to the cell surface on the order
of 30 min (Burgemeister et al., 1990). Therefore it is less like-
ly that a slow increase after induction (on the order of days)
is regulated by post-transcriptional mechanisms. A com-
parably slow rise in CD73 mRNA levels after induction has
in fact been described in other systems like HL60 cells
(Spychala et al., 1997) and vascular endothelial cells (Nar-
ravula et al., 2000). Comparable data for the A2a receptor
are not available in the literature. However, the IFN-γ driven
up-regulation of A2b receptor expression in murine
macrophages follows a similar slow time course (Xaus
et al., 1999). The equally slow decrease of CD73 and A2a in
P493-6 after turn on of EBNA2 (Figure 3) could be ex-
plained with a rather long half-life of the molecules once ex-
pressed on the cell surface. This is supported by observa-
tions on CD73 in human chorionic cells (W. Gutensohn,
unpublished) and would not be unusual for a GPI-anchored
molecule. For the A2a receptor this remains speculative.
Although the effects of induction and repression of
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Fig. 3 Time Course of CD73 Enzyme Activity and Adenosine
Receptor Responses in P493-6 Cells after a Change in Pheno-
type.
(A) CD73 activity after a switch from state 3 to state 1 (turn on of
EBNA2 in the presence of myc). Unchanged states 1 and
3 served as controls.
(B) cAMP production in response to 5 µM NECA 72 hours after a
switch from state 3 to 1 or 1 to 3, respectively (i.e. turn on or shut
off, respectively, of EBNA2 in the presence of myc). Unchanged
states 1 and 3 served as controls. CD73 activity and cAMP pro-
duction were determined as described in the legend to Figure 1.
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ecto-enzyme and receptor in this system are quite clear
cut, their biological significance for the P493-6 cells can-
not immediately be derived. Further studies should clari-
fy whether ecto-enzyme-supported signaling via the A2a
adenosine receptor would confer a survival advantage to
the cells in an otherwise resting state, i.e. when both mi-
togens are inactive.
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